drugset
drugset / Trial / NCT02671058

Pharmacokinetics and Bioavailability of Hydrocortisone Acetate Suppositories

NCT02671058 ↗

Phase 1 Completed 16 enrolled Cristcot LLC Parexel · collab
RandomizedCrossoverOpen-labelTreatment

Summary

This study will be an open label, single dose, randomized, 2 way (2 period) crossover study in healthy adult subjects at a single study center.

Timeline

Start
2016-03
Primary completion
2016-05-24
Completion
2016-05-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrocortisone Other / unclassified 90 mg Rectal
Subject Hydrocortisone Other / unclassified 100 mg Rectal

Indications

No indication recorded.